Technical Analysis for CALA - Calithera Biosciences, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Historical CALA trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 0.00% | |
| New Downtrend | Bearish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Wide Bands | Range Expansion | -8.79% | |
| Wide Bands | Range Expansion | -8.79% | |
| Upper Bollinger Band Walk | Strength | -11.70% | |
| Wide Bands | Range Expansion | -11.70% | |
| Overbought Stochastic | Strength | -11.70% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2019
- Sector: Healthcare
- Industry: Biotechnology
Calithera Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. Its lead product candidate includes CB-839, an inhibitor of glutaminase, which is in three Phase I clinical trials for the treatment of patients with solid tumors, leukemias, lymphomas, and multiple myeloma. The company was founded in 2010 and is headquartered in South San Francisco, California.
Medicine Biopharmaceutical Cancer Treatment Of Cancer Oncology Solid Tumors Tumor Lymphoma Multiple Myeloma Targeted Therapy Anatomical Pathology Hematology Lymphomas Phosphoinositide 3 Kinase Inhibitor Leukemias
Medicine Biopharmaceutical Cancer Treatment Of Cancer Oncology Solid Tumors Tumor Lymphoma Multiple Myeloma Targeted Therapy Anatomical Pathology Hematology Lymphomas Phosphoinositide 3 Kinase Inhibitor Leukemias
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 8.04 |
| 52 Week Low | 2.45 |
| Average Volume | 656,504 |
| 200-Day Moving Average | 4.61 |
| 50-Day Moving Average | 6.29 |
| 20-Day Moving Average | 6.81 |
| 10-Day Moving Average | 7.24 |
| Average True Range | 0.50 |
| ADX | 30.29 |
| +DI | 21.31 |
| -DI | 23.00 |
| Chandelier Exit (Long, 3 ATRs ) | 6.54 |
| Chandelier Exit (Short, 3 ATRs ) | 7.27 |
| Upper Bollinger Band | 7.88 |
| Lower Bollinger Band | 5.74 |
| Percent B (%b) | 0.42 |
| BandWidth | 31.40 |
| MACD Line | 0.28 |
| MACD Signal Line | 0.32 |
| MACD Histogram | -0.0365 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.63 | ||||
| Resistance 3 (R3) | 7.68 | 7.40 | 7.47 | ||
| Resistance 2 (R2) | 7.40 | 7.15 | 7.38 | 7.41 | |
| Resistance 1 (R1) | 7.02 | 6.99 | 6.88 | 6.97 | 7.35 |
| Pivot Point | 6.74 | 6.74 | 6.67 | 6.72 | 6.74 |
| Support 1 (S1) | 6.36 | 6.49 | 6.22 | 6.31 | 5.93 |
| Support 2 (S2) | 6.08 | 6.33 | 6.06 | 5.87 | |
| Support 3 (S3) | 5.70 | 6.08 | 5.82 | ||
| Support 4 (S4) | 5.65 |
